Read Our Latest Issue A rare genetic mutation might inspire the first broad-spectrum antiviral Viruses are notorious for evading man-made drugs, but they are powerless against a rare mutation in the gene . A person who possesses this mutation is better at fighting off most (if not all) of the viruses that plague humankind--but probably fewer than one person in 10 million has it. Dusan Bogunovic of the Icahn School of Medicine at Mount Sinai thinks it may be possible to develop a drug that mimics this mutation. If he is right, he may be on the verge of developing a pill that will temporarily bestow the ability to fight off a virus--any virus--without getting sick. The medication should also grant the person who takes it lifelong immunity to any strain encountered while on the drug (unless the virus mutates, as the flu does). This is a preview. Make a selection below to access this issue.Already have access? . Having trouble accessing this article? Please visit our page for more information Discover world-changing science. Explore our digital archive back to 1845, including articles by more than 150 Nobel Prize winners. Follow us Scientific american arabic (c) 2021 Scientific American, a Division of Springer Nature America, Inc. All Rights Reserved. Support our award-winning coverage of advances in science & technology. Already a subscriber? Subscribers get more award-winning coverage of advances in science & technology.